Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000315

Drug Information
NameThiethylperazine
SynonymsThiethylperazine (USAN/INN); Thiethylperazinum [INN-Latin]; AB00514742; CHEMBL1378; ETHYLTHIOPERAZINE; 52239-63-1 (malate (1:2)); AC1L1KCZ; NSC130044; 3-Ethylmercapto-10-(1'-methylpiperazinyl-4'-propyl)phenothiazine; UNII-8ETK1WAF6R; Norzine (*Dimaleate*); DB00372; L000871; Thiethylperazinum; LS-105543; Thiethylpipezazine; GS-95 (*Dimaleate*); HSDB 3400; EINECS 215-819-0; D02354; 1179-69-7 (maleate (1:2)); Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-; 2-(ethylsulfanyl)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine; Torecan; Thiethylperazine [USAN:INN:BAN]; CID5440; Theithylperazine; Tietilperazina; C07132; 1420-55-9; Tietilperazina [DCIT]; 10H-Phenothiazine, 2-(ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]-; 2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine; Thioethylperazine; 10H-Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-; CHEBI:9544; C22H29N3S2; 2-(Ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine; 2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine; 10H-Phenothiazine, 2-(ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]-, (Z)-2-butenedioate (1:2); thiethylperazine
Trade NameTorecan
CompanyNorvatis Phamaceuticals Corporation
IndicationNausea and vomiting
[ICD9: 787, 787.0   ICD10: R11]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C22H29N3S2/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-
22)12-6-11-24-15-13-23(2)14-16-24/h4-5,7-10,17H,3,6,11-16H2,1-2H3
InChIKeyXCTYLCDETUVOIP-UHFFFAOYSA-N
Canonical SMILESCCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C    
Therapeutic ClassAntiemetics
CAS NumberCAS 1420-55-9
FormulaC22H29N3S2
PubChem Compound IDCID 5440.
PubChem Substance IDSID 9342.
ChEBI9544;
SuperDrug ATC IDR06AD03
SuperDrug CAS ID001420559;
TargetDopamine receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 012753 To Reference
Ref 2Antiemetic specificity of dopamine antagonists. Psychopharmacology (Berl). 1982;78(3):210-3. To Reference
Ref 3Torecan-induced neuroleptic malignant syndrome. Harefuah. 1990 May 15;118(10):576-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543